Up to 15% of pediatric and adult AML is mediated by mutations of CEBPA. Germline CEBPA mutations may develop into early-onset AML following subsequent somatic mutation acquisition [62,63]. The gene discussed is CEBPA; the disease is acute myeloid leukemia.